We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Illustration

Siemens Begins Delivering CE-IVD Registered Coronavirus SARS-CoV-2 Test Kit

Siemens Healthineers (Erlangen, Germany) has registered its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay2 test kit for diagnostic use with the Luxembourg Ministry of Health, allowing for its immediate rollout for diagnostic use in Europe. More...
30 Apr 2020
Illustration

Molecular Diagnostics (MDx) And Lateral Flow Assays (LAFs) Dominate COVID-19 Diagnostics, Says New Report

The need for universal and massive testing across the population has led to a race for technology innovations for COVID-19 diagnostics. From the technological perspective, molecular diagnostics (MDx) and lateral flow assays (LAFs) dominate COVID-19 diagnostics. More...
30 Apr 2020
Image: A new test quickly detects SARS-CoV-2 (spheres) through binding to antibodies (Y-shapes) on a field-effect transistor (Photo courtesy of adapted from ACS Nano 2020, DOI: 10.1021/acsnano.0c02823).

Rapid Diagnostic Sensor Detects COVID-19 Directly from Swab Extracts

A team of South Korean researchers has developed a diagnostic tool for the rapid detection of coronavirus from swab samples with no preparation steps. More...
30 Apr 2020
Image: BIOTECON Diagnostics microproof SARS-CoV-2 Screening Identification Kits (Photo courtesy of BIOTECON Diagnostics)

BIOTECON Launches Microproof SARS-CoV-2 Screening/Identification Kits

BIOTECON Diagnostics (Potsdam, Germany) has developed and launched its own microproof® SARS-CoV-2 Screening/Identification Kits, which are available immediately for purchase and can be distributed globally. More...
29 Apr 2020
Image: DiaSorin’s LIAISON platform (Photo courtesy of DiaSorin)

DiaSorin’s LIAISON SARS-CoV-2 S1/S2 IgG Test Receives FDA Emergency Use Authorization

DiaSorin (Saluggia, Italy) has received Emergency Use Authorization (EUA) from the US Food and Drug Administration for its LIAISON SARS-CoV-2 S1/S2 IgG test. More...
29 Apr 2020
Image: ErbaLisa COVID-19 IgG Antibody ELISA (Photo courtesy of Erba Mannheim)

ERBA Mannheim Launches CE Marked COVID-19 Antibody ELISA Kits

Erba Mannheim (London, England) has launched its ErbaLisa COVID-19 ELISA kits for detection of IgG and IgM antibodies to SARS-CoV-2. The assays have been designed for use either manually or with any open automated ELISA analyzer, such as the Erba Mannheim ELAN 30s. More...
29 Apr 2020
Illustration

The IFCC Launches Online Resource for COVID-19 Diagnostics

The International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), the umbrella organization encompassing national societies in the field in nearly 100 countries around the world, established an online resource providing key information on laboratory guidelines, biosafety, and other important matters to assist clinical laboratories as they face the challenges posed by the COVID-19 outbreak. More...
28 Apr 2020
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay
New
PSA Test
Human Semen Rapid Test